Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Join/Renew
ASA Community
ASA Home
Code of Conduct
Volunteer
Skip main navigation (Press Enter).
Toggle navigation
Search Options
Home
About Us
Join
Executive Committee
Sub-Committees
-Mentoring Program Committee
-Funding Program Committee
-Next Generation Stewardship Committee
-Fellows Committee
-Membership Committee
-Scientific Working Group Proposal Committee
-Leadership-in-practice Committee
-Statisticians in Small Biotech
Overview
EC Meeting Minutes
History
BIOP Turns 40
Charter
Join
Related Links
Manual of Operations
Working Groups
Alzheimer's Disease
Bayesian Scientific Working Group
Cell & Gene Therapy
Centralized Statistical Monitoring and Quality Tolerance Limits
Covariate Adjustment Scientific Working Group
Estimands in Oncology
Nonclinical Biostatistics
Pediatric Drug Development
Real World Evidence Scientific Working Group
Re-Randomization
Safety Scientific Working Group
Software Engineering Working Group
Statistical Methods in Oncology
Biopharmaceutical Software Working Group - Retired Group
Health Technology Assessment Scientific Working Group
Statistics and Pharmacometrics
Events
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
ASA Biopharmaceutical Section Nonclinical Biostatistics Conference
STATBOLIC 2025
Upcoming ASA Webinars
Biopharmaceutical Event Calendar
General Calendar
Media Contents
Webinar Archive
Podcasts
BIOP Youtube Channel
Biopharmaceutical Report
Directory
Awards
Best Nonclinical Paper
ASA Fellow Members in the Biopharmaceutical Section
Student Paper Competition
Scholarship Award
Past Award Winners
Real World Evidence Scientific Working Group
Home
Who We Are
Projects
Presentations
Manuscripts
☰
Session on Utility of Real-World Evidence in Medical Product Development and Life Cycle Management (ASA BIOP RISW 2018)
Emerging Opportunities for Utilizing Real-World Evidence to Impact Drug Development and Regulatory Decision-Making (Topic-contributed JSM 2019)
Recent Statistical Developments in Considering Real World Evidence for Regulatory Decision Making (2019 JSM)
Session on Challenges and Opportunities in the Use of Real-World Evidence in Regulatory Decision-Marking of Medical Products: An ASA BIOP RWE SWG Progress (ASA BIOP RISW 2019)
Invited session on Translating Real-World Data into Real-World Evidence for Regulatory Decisions and Medical Practice: Opportunities and Challenges (JSM 2020)
Session on Addressing Challenges and Opportunities in the Use of Real-World Evidence in Regulatory Decision-Marking of Medical Products: ASA BIOP RWE SWG Interim Progress report (ASA BIOP RISW 2020)
Session on Key Steps in Deriving Real-World Evidence from Analysis of Real-World Data –Topic-Contributed Papers (2021 JSM)
Session on Addressing Key Issues to Promote the Uptake of Using RWE/D for Regulatory Decisions – Topic-Contributed Papers (2022 JSM)
Skip Navigation Links
Privacy Policy
Report a Problem
Copyright © 2011 ASA. All rights reserved.
Powered by Higher Logic
×
Community Tags
Add a tag
x
User Tags may not contain the following characters: @ # $ & :